跳至主要内容
临床试验/ACTRN12622000996763
ACTRN12622000996763已完成未知

Pharmacist-led Intervention for Disease and Risk Management in Patients with Ischemic Heart Disease

Dr. Amjad Khan0 个研究点目标入组 330 人开始时间: 2022年7月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
330

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients with confirmed ischemic heart diseases (e.g Myocardial infarction, angina, history of atherosclerosis) who are admitted to and taking follow-up treatment in the Punjab Institute of Cardiology (PIC) hospital will be recruited for the study. Patients with a previous history of coronary heart disease will also be included. Informed consent will be taken from the patients before conducting the study

排除标准

  • Cardiovascular patients other than ischemic heart diseases will be excluded from the study. Patients who have a shorter stay in the hospital, do not have to ability to self-care, cognitively impaired patients, allergic or contraindicated to cardiovascular medicines, have communicable diseases, and could not complete the study due to hepatic or renal insufficiencies and refused to include in the study would be excluded from the study.

研究者

发起方
Dr. Amjad Khan

相似试验